Outside of those four states, consumers must put their trust in the manufacturer. Sometimes that’s warranted, and sometimes it’s not. In 2016 and 2016, the FDA ran tests on several CBD products and found that many of the products had far less CBD than advertised, and in some cases none at all. You can find those test results here for 2015, and here for 2016. (These FDA tests were done as a one-off project. CBD products are not approved by the FDA for the prevention, mitigation, or treatment of any disease or condition.)
Crazy thing is that there are some stores that are actually selling CBD oil for vapes and ingestion and they are not paying attention that it actually states on the back of the package “contains <3% THC" (which is illegal in WY). But you are correct there are lots of places in WY that throw the book at you for petty little shit and let the harder criminals off with a slap on the wrist. Sucks
CBD oil acts on the body’s endocannabinoid system. The endocannabinoid system (ECS) is found in all mammals and contains CB1 and CB2 receptors, more receptors than any other system in the human body. Human bodies naturally produce endocannabinoids, which in turn, act on the receptors to produce a physiologic response. CBD introduces extra cannabinoids into the ECS and can help to regulate many of the body’s functions. CBD gives your body more of what it already produces to promote health, well-being and return to homeostasis.
The key is to effectively gauge exactly how much CBD oil it takes to start managing your pain. If you start off right away with a maximum dose of a 600 mg tincture, you will have no idea how much of the product it actually took to treat your condition, and how much you wasted (this is also important because you do not want to exceed dosage and end up developing a tolerance to the active cannabinoids).
In addition to all the benefits we’ve already discussed, CBD has been proven to have antioxidant and neuroprotective effects. This means that it helps repair the damage from oxidative stress, which is believed to be a primary cause of diseases like Alzheimer’s, Parkinson’s, ALS — even heart disorders and some forms of cancer. This is a hugely beneficial effect of CBD.
When CBD oil interacts with our brains’ and other receptors, it promotes and produces painkilling effects and anti-inflammatory. Interaction with a cellular level ECS, CBD greatly reduces the instances and severity of neuropathic or chronic pain, as it also increases the body’s serotonin production at the same time. On consuming CBD, the chemical effects in the bodywork for the benefit of people suffering from all types of chronic pains like in the joint, knee, and back.
The endocannabinoid system is spread throughout your brain and body, but primarily throughout your central nervous system. The interaction between cannabinoids and receptors is what produces effects like the regulation of mood, pain, appetite, inflammation, and memory. Plant-based cannabinoids, found in cannabis plants, also interact with the receptors (whimsically named CB1 and CB2) in the endocannabinoid system, and each affects your body in different ways. CBD and its infamous cousin THC are the 2 most well-known cannabinoids.
Unfortunately, due to strict FDA laws, I am not legally able to say that CBD will help with your specific condition, with that being said, you would need to buy the filled cartridges if you are using a pen that uses the screw on cartridges. Otherwise if you have a vape that has a tank on it you can buy our vape oil and do it that way. I hope this helps. Feel free to email [email protected]
As mentioned above, CBD is no longer considered a Schedule I controlled substance under the Farm Act. However, under the DEA’s definition, it remains on the list. This allows for individual states to create exceptions to the status of CBD, even when cultivated from hemp plants grown legally under the act. It also maintains illegal status for any CBD sourced from plants produced in settings that are not consistent with that Act, or by an unlicensed grower. It is expected that more clarification on the status of CBD will come early this year (2019).